Ensign Peak Advisors, Inc Syndax Pharmaceuticals Inc Transaction History

Ensign Peak Advisors, Inc

$51.2 Billion
Q1 2025

A detailed history of Ensign Peak Advisors, Inc transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 689,064 shares of SNDX stock, worth $10.7 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

689,064

Previous 267,949 157.16%

Holding current value

$10.7 Million

Previous $3.54 Million 139.07%

% of portfolio

0.02%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$12.29 - $16.38 $5.18 Million - $6.9 Million	421,115 Added 157.16%	689,064 $8.47 Million
Q4 2024 Feb 13, 2025	SELL	$12.52 - $21.81 $1.18 Million - $2.05 Million	-93,876 Reduced 25.95%	267,949 $3.54 Million
Q3 2024 Nov 14, 2024	SELL	$17.93 - $24.81 $2.82 Million - $3.9 Million	-157,060 Reduced 30.27%	361,825 $6.97 Million
Q2 2024 Aug 13, 2024	BUY	$18.82 - $23.79 $75,901 - $95,945	4,033 Added 0.78%	518,885 $10.7 Million
Q3 2023 Nov 13, 2023	BUY	$14.52 - $21.77 $1.84 Million - $2.75 Million	126,500 Added 32.57%	514,852 $7.48 Million
Q2 2023 Aug 14, 2023	BUY	$19.35 - $22.31 $2.96 Million - $3.41 Million	152,982 Added 65.0%	388,352 $8.13 Million
Q4 2022 Feb 13, 2023	BUY	$20.64 - $26.24 $495,401 - $629,812	24,002 Added 11.36%	235,370 $5.99 Million
Q3 2022 Nov 14, 2022	BUY	$18.51 - $24.79 $1.58 Million - $2.11 Million	85,177 Added 67.5%	211,368 $5.08 Million
Q2 2022 Aug 12, 2022	BUY	$13.64 - $19.48 $892,792 - $1.28 Million	65,454 Added 107.77%	126,191 $2.43 Million
Q4 2021 Feb 11, 2022	SELL	$15.23 - $22.47 $2.1 Million - $3.1 Million	-137,865 Reduced 69.42%	60,737 $1.33 Million
Q3 2021 Nov 12, 2021	BUY	$13.87 - $19.8 $1.98 Million - $2.82 Million	142,484 Added 253.9%	198,602 $3.8 Million
Q1 2021 May 12, 2021	BUY	$19.28 - $24.59 $291,918 - $372,317	15,141 Added 36.95%	56,118 $1.25 Million
Q3 2020 Nov 12, 2020	BUY	$13.39 - $17.48 $308,277 - $402,442	23,023 Added 128.23%	40,977 $604,000
Q2 2020 Aug 12, 2020	BUY	$8.94 - $20.98 $56,724 - $133,118	6,345 Added 54.66%	17,954 $266,000
Q1 2020 May 11, 2020	SELL	$6.65 - $12.03 $77,206 - $139,668	-11,610 Reduced 50.0%	11,609 $127,000
Q4 2019 Feb 14, 2020	BUY	$5.43 - $9.22 $126,079 - $214,079	23,219 New	23,219 $204,000

Others Institutions Holding SNDX

# of Institutions

247

Shares Held

100M

Call Options Held

1.28M

Put Options Held

1.29M

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $882M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Account

Ensign Peak Advisors, Inc Syndax Pharmaceuticals Inc Transaction History